Systems and methods to place one or more leads in tissue to electrically stimulate nerves of passage to treat pain

US9895530B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9895530-B2
Application numberUS-201213605653-A
CountryUS
Kind codeB2
Filing dateSep 6, 2012
Priority dateDec 5, 2008
Publication dateFeb 20, 2018
Grant dateFeb 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems and methods are provided for applying electrical stimulation to a body by an electrode spaced from a target nerve of passage. It has been discovered that pain felt, or perceived to be felt, in a given region of the body can be treated by stimulating muscle close to a “nerve of passage” in a region that is superior (i.e., cranial or upstream toward the spinal column) to the region where pain is felt, such as in a case of post-amputation residual limb pain, or purportedly felt in the case of post-amputation phantom limb pain.

First claim

Opening claim text (preview).

We claim: 1. A method of reducing a perception of pain by a human body, the method comprising the steps of: placing an electrode at a therapeutically effective distance spaced from a neural fiber bundle within said body, wherein said neural fiber bundle comprises at least one of a Type Ia and Ib afferent nerve fiber with at least one of Type III and Type IV nerve fibers; and delivering electrical stimulation from said electrode to said neural fiber bundle to reduce a perception of pain by said human, wherein said at least one Type Ia and Ib afferent nerve fiber of said neural fiber bundle are selectively activated while minimizing recruitment of activation of said at least one of Type III and Type IV nerve fiber of said neural fiber bundle due to the electrode being at the therapeutically effective distance. 2. A method according to claim 1 , wherein said placing step is performed without incising a skin surface of said human body. 3. A method according to claim 1 , wherein said electrode is disposed on a lead comprising at least one conductive wire. 4. A method according to claim 3 , wherein during said delivering step, said conductive wire extends through a skin surface of said body. 5. A method according to claim 4 , wherein said delivering step is performed for a predetermined amount of time and said conductive wire remains extended through said skin surface throughout said predetermined amount of time. 6. A method according to claim 5 , wherein said predetermined amount of time comprises about two weeks to about four weeks. 7. A method according to claim 5 , wherein said electrode is removed from said body after said predetermined amount of time. 8. A method according to claim 5 , wherein said reduction in perception of pain continues beyond said predetermined amount of time. 9. A method according to claim 8 , wherein said reduction in perception of pain continues for at least as long as said predetermined amount of time beyond said predetermined amount of time. 10. A method according to claim 9 , wherein said reduction in perception of pain continues for at least twice as long as said predetermined amount of time beyond said predetermined amount of time. 11. A method according to claim 1 , wherein the reduction in perception of pain comprises an at least thirty percent reduction in pain. 12. A method according to claim 1 , wherein said therapeutically effective distance is greater than one centimeter. 13. A method according to claim 1 , wherein said therapeutically effective distance is about 0.2 centimeters to about 3.0 centimeters. 14. A method according to claim 13 , wherein said therapeutically effective distance is about five millimeters to about twenty millimeters. 15. A method according to claim 1 , wherein said neural fiber bundle comprises said Type Ia and Ib afferent nerve fibers and Type III and Type IV nerve fibers. 16. A method according to claim 1 , wherein said neural fiber bundle comprises said Type Ia afferent nerve fiber. 17. A method according to claim 1 , wherein said neural fiber bundle comprises said Type III nerve fiber. 18. A method according claim 1 , wherein said nerve fiber bundle includes an efferent nerve fiber and further comprises minimizing recruitment of activation of said efferent nerve fiber of said neural fiber bundle. 19. A method of reducing a perception of pain by a human body, the method comprising the steps of: placing an electrode at a therapeutically effective distance spaced from a neural fiber bundle within the body, wherein said neural fiber bundle comprises at least one of a Type Ia and Ib afferent nerve fiber plus an efferent nerve fiber; and delivering electrical stimulation from said electrode to said neural fiber bundle to reduce a perception of pain by said human, wherein said at least one of Type Ia and Ib afferent nerve fiber of said neural fiber bundle are selectively activated while minimizing recruitment of activation of said efferent nerve fiber of said neural fiber bundle due to the electrode being at the therapeutically effective distance. 20. A method according to claim 19 , wherein selectively activating at least one of said Type Ia and Ib afferent nerve fibers includes selectively activating both of said Type Ia and Ib afferent nerve fibers. 21. A method according to claim 19 , wherein minimizing recruitment of activation includes minimizing recruitment of activation of at least one of a Type III and Type IV nerve fiber of said neural fiber bundle. 22. A method according to claim 21 , wherein minimizing recruitment of activation includes minimizing recruitment of activation of both said Type III and Type IV nerve fibers of said neural fiber bundle. 23. A method according to claim 19 , wherein said electrode is a monopolar electrode. 24. A method according to claim 19 , wherein said electrode is operably coupled with a coiled fine wire lead. 25. A method according to claim 19 , wherein said electrode is a multi-contact electrode whereby only a single electrode delivers electrical stimulation. 26. A method according to claim 19 , wherein said electrode includes a distal end whereby said distal end encourages in-growth of connective tissue. 27. A method of reducing a perception of pain by a human body, the method comprising the steps of: placing an electrode at a therapeutically effective distance spaced from a neural fiber bundle within said body, wherein said neural fiber bundle comprises more than one type of nerve fiber, wherein said therapeutically effective distance is about 0.2 centimeters to about 3.0 centimeters from said neural fiber bundle; and delivering electrical stimulation from said electrode to said neural fiber bundle to reduce a perception of pain by said human, wherein a first of said type of nerve fiber is selectively activated while minimizing recruitment of activation of a second of said type of nerve fiber due to the electrode being at the therapeutically effective distance, wherein said second of said type of nerve fiber includes at least one of a Type III, Type IV and efferent nerve fiber. 28. A method according to claim 27 , wherein said first of said type of nerve fiber includes at least one a Type Ia and Type IB afferent nerve fiber. 29. A method according to claim 28 , wherein said second of said type of nerve fiber includes said Type III and Type IV nerve fibers. 30. A method according to claim 29 , wherein said first of said type of nerve fiber includes Type Ia and Type IB afferent nerve fibers. 31. A method according to claim 27 , wherein said therapeutically effective distance is about five millimeters to about twenty millimeters. 32. A method according claim 27 , wherein said second of said type of nerve fiber includes said efferent nerve fiber.

Assignees

Inventors

Classifications

  • Anchoring or fixation means therefor · CPC title

  • Pain · CPC title

  • A61N1/0551Primary

    Spinal or peripheral nerve electrodes · CPC title

  • with leads or electrodes penetrating the skin · CPC title

  • Specially adapted for transcutaneous electrical nerve stimulation [TENS] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9895530B2 cover?
Systems and methods are provided for applying electrical stimulation to a body by an electrode spaced from a target nerve of passage. It has been discovered that pain felt, or perceived to be felt, in a given region of the body can be treated by stimulating muscle close to a “nerve of passage” in a region that is superior (i.e., cranial or upstream toward the spinal column) to the region where …
Who is the assignee on this patent?
Boggs Ii Joseph W, Zang Rosemary H, Spr Therapeutics Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/0551. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).